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Intricate networks of direct and coordinated interactions between proteins and nucleic acids are of vital importance in the regu-lation of numerous cellular processes, such as gene expression, 
DNA replication or DNA repair1. Robust methods that can inter-
rogate these interaction networks in a native chromatin context 
are key to understand the underlying molecular mechanisms2,3. 
Chromatin immunoprecipitation (ChIP) has been coupled with 
mass spectrometry (MS)-based proteomics analysis to character-
ize the composition of particular chromatin-associated protein 
complexes4–6. However, these approaches require high-affinity 
and high-selectivity antibodies that typically explore one protein 
of interest at a time. Alternatively, enzyme-catalysed proximity 
labelling approaches, such as BioID or APEX, target promiscuous 
labelling enzymes to specific proteins of a subcellular compartment 
by genetic fusion, by which they promote the covalent tagging of 
endogenous neighbouring proteins3,7. Despite several successful 
examples, applicability and spatial resolution can be hindered by 
relatively slow labelling kinetics, toxicity and the size of the engi-
neered fusion proteins8.
In contrast, photoactivation of small-molecule crosslinkers 
allows for a precise control of the reaction and shorter labelling 
times to provide relatively low background binding and good spatial 
and temporal resolution9. In affinity-based protein profiling, small 
molecules are linked to photocrosslinkers that mediate the irrevers-
ible binding to cellular protein targets in situ, followed by character-
ization via quantitative proteomics10,11. However, such approaches 
have so far been used to map direct protein interactors of drugs 
or small-molecule fragments12,13 rather than interaction networks. 
Thus, novel strategies that circumvent these limitations and provide 
a more holistic view of protein interactions at particular functional 
genomic sites are highly required.
DNA G-quadruplexes (G4s) are non-canonical, four-stranded 
nucleic acid structures that comprise stacked G-tetrads within 
certain G-rich sequences (Fig. 1a)14,15. DNA G4s have been shown 
to exist in human cells16–18, and their formation is dynamic in live 
cells19. G4 sequencing (G4-seq) identified more than 700,000 sites 
in human genomic DNA that have the biophysical potential to form 
G4s (potential G4s)20. G4 chromatin immunoprecipitation sequenc-
ing (G4 ChIP-seq)21 found endogenous DNA G4s enriched in 
open chromatin regions and promoters of highly expressed cancer 
genes22, and these G4s were recently linked to underlying transcrip-
tion factor programmes in breast cancer23. Notably, the formation 
of endogenous G4s is cell-type specific with only 1% (~10,000 sites) 
of the in vitro potential G4s20 being detected in chromatin21. Taken 
together, these data suggest that G4 folding in chromatin is dynamic 
and that G4 homeostasis and functions may be intricately linked 
to interacting proteins24. A variety of proteins, such as helicases25,26, 
transcription factors27–29 and epigenetic modulators30, have been 
shown to interact with DNA G4s in vitro. However, DNA G4 bind-
ing proteins have mostly been explored by affinity enrichment from 
lysed samples using synthetic G4 oligonucleotides as baits31–33. Such 
affinity purification experiments do not account for the native chro-
matin environment, which is intricately linked to G4 biology22.
Here, we report a co-binding-mediated protein profiling (CMPP) 
approach for the investigation of DNA G4-interacting proteins in 
living cells. In this strategy, functionalized small-molecule ligands 
are designed to bind G4 structures in cellular chromatin, which 
serve as docking sites to bring the probes into close proximity to 
the G4-interacting proteins and enable labelling by subsequent pho-
tocrosslinking (Fig. 1b). We first showed that this concept can be 
efficiently applied with minimal perturbation of G4-protein inter-
actions by photoproximity crosslinking of a G4-binding antibody 
in vitro. We then employed this approach in human cells to identify 
hundreds of putative G4-interacting proteins that comprised diverse 
functional classes. Next, we characterized the G4 binding properties 
for a representative set of proteins in vitro and found strong and 
selective G4 binding interactions for several of the novel candidates. 
Lastly, we further investigated one of the candidates, the chromatin 
remodeller SMARCA4, and revealed its recruitment to endogenous 
promoter G4s in chromatin.
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DNA–protein interactions regulate critical biological processes. Identifying proteins that bind to specific, functional genomic loci 
is essential to understand the underlying regulatory mechanisms on a molecular level. Here we describe a co-binding-mediated 
protein profiling (CMPP) strategy to investigate the interactome of DNA G-quadruplexes (G4s) in native chromatin. CMPP 
involves cell-permeable, functionalized G4-ligand probes that bind endogenous G4s and subsequently crosslink to co-binding 
G4-interacting proteins in situ. We first showed the robustness of CMPP by proximity labelling of a G4 binding protein in vitro. 
Employing this approach in live cells, we then identified hundreds of putative G4-interacting proteins from various functional 
classes. Next, we confirmed a high G4-binding affinity and selectivity for several newly discovered G4 interactors in vitro, and 
we validated direct G4 interactions for a functionally important candidate in cellular chromatin using an independent approach. 
Our studies provide a chemical strategy to map protein interactions of specific nucleic acid features in living cells.
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results
Design of co-binding-mediated protein profiling. A small mol-
ecule that binds a variety of G4 DNA target structures in cells could 
be functionalized to allow mapping of G4-interacting proteins in 
their native environment with minimal perturbation (Fig. 1b). We 
based our probe design on pyridostatin (PDS), a highly G4-selective 
small-molecule ligand that has been widely used to target DNA and 
RNA G4s in cells34. We previously showed that a PDS derivative and 
a protein can simultaneously bind a G4 in vitro35, which makes a 
promising molecular scaffold to detect co-binding proteins.
We prepared two G4-ligand probes, photoPDS-1 (1) and 
photoPDS-2 (2) (Fig. 2a), by tethering PDS to a click alkyne handle 
and a photoreactive aliphatic diazirine group, which is small and 
has excellent chemical stability, photolabelling efficiency and low 
background binding36,37. Probe 1 has a short, two-carbon linker and 
probe 2 has a two-unit polyethylene glycol longer linker (12 atoms) 
to enable probing proteins at different distances from the G4 bind-
ing site. In addition, we prepared a photoactivatable control 3  
(Fig. 2a) that lacks a G4 binding moiety.
First, we assessed the binding affinity and selectivity of the 
probes towards G4 structures using an established fluorescence 
resonance energy transfer melting assay38. Compared with the par-
ent compound PDS, both 1 and 2 retained the capacity to bind 
and stabilize a panel of G4 oligonucleotides (G4 Kit1, G4 Myc and 
G4 Telo) (Supplementary Table 1) and showed negligible stabili-
zation of double-stranded DNA (dsDNA) (Fig. 2b and Extended 
Data Fig. 1a). Furthermore, fluorescence quench binding assays39 
confirmed that 1 and 2 exhibit strong and selective binding to 
different G4 structures (Supplementary Table 2), such as G4 Myc 
with an apparent dissociation constants (Kd) of 197 ± 10 nM and 
439 ± 36 nM, respectively (Fig. 2c), comparable to that of PDS bind-
ing (Kd = 168 ± 8 nM; Extended Data Fig. 1b). In contrast, 3 showed 
no apparent G4 binding (Fig. 2b and Extended Data Fig. 1a,b).
Photoproximity labelling of a G4 binding protein in vitro. As a 
proof of concept, we tested the probes using the G4-specific anti-
body BG417 in vitro (Fig. 2d). BG4 was incubated with a folded G4 
Myc oligonucleotide that forms a well-characterized G4 structure, as 
well as incubation with non-G4 control oligonucleotides, such as a 
mutated single-stranded Myc (ss mutMyc) and a double-stranded 
Myc (ds Myc). The presence or absence of G4 formation was con-
firmed by circular dichroism spectroscopy (Extended Data Fig. 1c). 
Probes 1 and 2, as well as control 3, were then incubated with 
the pre-incubated BG4–oligonucleotides mixtures and photocross-
linked at 365 nm. For each case, the probe was subsequently con-
jugated with tetramethylrhodamine-azide (TAMRA-azide) via the 
copper-catalysed azide–alkyne cycloaddition click reaction40, and 
the protein–oligonucleotide–probe mixtures were each separated by 
denaturing sodium dodecyl sulfate–polyacrylamide gel electropho-
resis (SDS–PAGE) and then visualized by in-gel fluorescence scan-
ning. We observed dose-dependent labelling of G4-Myc-bound BG4 
by both probes 1 and 2 (Fig. 2e and Extended Data Fig. 1d), whereas 
negligible labelling was observed for control 3 (Fig. 2e). In addition, 
no labelling was observed in the presence of the control oligonucle-
otides ss mutMyc and ds Myc or in the absence of an oligonucleotide. 
This demonstrates for both probes 1 and 2 that crosslinking is made 
possible by co-binding to a G4 structure. In the case of BG4, labelling 
by probe 1 with the short linker, also suggests that the probe and BG4 
co-bind to G4s in close proximity. The proof-of-concept paved the 
way for experiments to identify G4 binding proteins in cells.
Global profiling of DNA G4-interacting proteins in cells. We 
next employed our approach to identify G4-interacting proteins 
in human cells. Embryonic kidney HEK293T cells were treated 
with probes 1 and 2, and control 3 (20 μM), followed by photo-
crosslinking at 365 nm. The nuclear extract was conjugated with 
TAMRA-azide via the copper-catalysed azide–alkyne cycloaddition 
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Fig. 1 | Schematic for CMPP. a, A G-tetrad stabilized by Hoogsteen base pairing and a monovalent cation (top), and an intramolecular G4 structure formed 
by the stacking of G-tetrads (bottom). b, Schematic representation of the CMPP concept. Cells are treated with G4-ligand probes that are functionalized 
with a photoreactive diazirine group and a click alkyne handle. The probes are recruited to endogenous G4 binding sites, where ultraviolet irradiation 
triggers the proximity capture of co-binding G4-interacting proteins.
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reaction, separated by SDS–PAGE and visualized by in-gel fluores-
cence scanning (Fig. 3a)13. We observed distinct bands over a range 
of concentrations for both probes 1 and 2 (Fig. 3b and Extended 
Data Fig. 2a,b), which confirmed specific protein labelling as well 
as a good cell permeability and nuclear uptake, although probe 1 
displayed a slightly higher efficiency. In addition, the probes did 
not show cell toxicity under the treatment conditions employed 
(Extended Data Fig. 2c).
Next, to identify the target proteins captured by G4-ligand probes, 
we employed a label-free, quantitative liquid chromatography (LC)–
MS proteomics approach4. After photocrosslinking and extraction 
of the nuclear lysate, proteins were conjugated to biotin-azide and 
affinity purified on streptavidin beads, followed by on-bead diges-
tion and quantitative LC–MS/MS analysis (Fig. 3a). Proteins that 
were detected in at least two out of four biological replicates and 
appeared significantly enriched over the non-specific probe 3 (fold 
change (FC) >2, false discovery rate (FDR) <0.05) were considered 
as candidate G4-interacting proteins. In total, we obtained 248 and 
209 enriched protein targets for 1 and 2, respectively, from diverse 
functional classes (Fig. 3c,d). Interestingly, probe 2 shares ~96% 
(201 out of 209) of candidates with 1 (Fig. 3e), which suggests the 
linker length was not critical, in line with our observations for single 
protein BG4 labelling in vitro. Some of the candidate G4-interacting 
proteins overlapped with previously reported G4-interacting pro-
teins41 for both probes 1 (19/79, 24%) and 2 (11/79, 14%), which 
provides independent corroboration for some of the findings, as 
well as new candidates, with our method.
Analysis of the annotated biological processes (Methods) 
revealed that the identified candidates are implicated in various 
different nuclear processes (Fig. 3f). In particular, we observed a 
large number of proteins involved in transcription, which is con-
sistent with the emerging role of DNA G4s in transcriptional reg-
ulation24. Among the enriched proteins from diverse functional 
classes (Fig. 3g), we identified 19 of previously reported G4 inter-
actors, such as hnRNP A142 and nucleolin32. Importantly, we iden-
tified numerous novel candidate G4 interactors, such as a master 
epigenetic regulator UHRF1, transcription termination factor 
TTF2, ATP-dependent RNA helicases (for example, DDX1 and 
DDX24) and pre-mRNA-splicing factor RBM22, that have been 
shown to have a direct association with chromatin43. Interestingly, 
we also identified several subunits of the chromatin remodelling 
complex SWI/SNF (SWItch/sucrose non-fermentable), such as 
SMARCA4 and SMARCC1, which have only recently been linked to 
DNA G4s31,44.
Characterization of candidate proteins in vitro. Candidate 
G4-interacting proteins identified by co-binding-mediated prox-
imity labelling could potentially bind to G4 directly or as part of a 
protein complex bound to G4 or in close proximity to G4s. To better 
characterize the binding properties for a selection of candidate pro-
teins, we employed a selection of 3′-biotinylated, well-characterized 
G4 oligonucleotides that can form different types of G4 structures, 
which include parallel (Myc, Kit1 and Kit2), antiparallel (TBA) and 
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Fig. 2 | Co-binding-mediated proximity capture of a G4 binding protein in vitro. a, Chemical structures of G4-ligand probes photoPDS-1 (1), photoPDS-2 
(2) and the control probe 3. b, Thermal melting shifts of G4 Kit1 (left) and dsDNA (right) induced by increasing concentrations of 1, 2 and 3. The increase 
in melting temperature (ΔTm) was measured by a fluorescence resonance energy transfer melting assay. The mean is from two independent experiments 
(n = 2). c, Fluorescence quenching induced by increasing the concentrations of probes 1, 2 and 3 bound to different G4 structures (G4 Myc, G4 Kit1 and 
G4 Telo) and dsDNA. The apparent Kd values are shown. Mean and error (± standard deviation (s.d.)) are from four independent experiments (n = 4). 
d, Schematic representation of the co-binding-mediated proximity capture of BG4 in vitro. e, Gel scans (probe, 10 μM) showing fluorescence images of 
co-binding-mediated proximity labelling of BG4 (molecular mass ~31 kDa) by 1, 2 and 3. Representative images from three independent experiments with 
similar results are shown.
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mutated single-stranded mutant sequences that cannot fold into 
G4s and dsDNA were used as controls (Extended Data Fig. 3). The 
oligonucleotides were immobilized on streptavidin beads and used 
to affinity-enrich target proteins from HEK293T nuclear lysates, 
followed by western blot analysis. We investigated a selection of 
candidates identified by CMPP (SMARCA4, UHRF1, RBM22, 
TTF2, DDX24, DDX1 and HMGB2) that represent a variety of 
different functional protein classes (Fig. 3c,d). Strikingly, six out 
seven candidates showed G4-specific binding compared with that 
of the corresponding controls (Fig. 4a and Supplementary Table 4). 
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Fig. 3 | Profiling of G4 interactomes in human cells. a, Schematic workflow of the in situ mapping of G4-interacting proteins in HEK293T cells.  
b, Gel-based global profiling of G4-interacting proteins using probes (20 μM) 1 and 2 versus 3. TAMRA and Coomassie staining represent probe-specific 
labelling and total loading proteins, respectively. A representative image from three independent experiments with similar results is shown. c, Volcano plot 
displaying enriched proteins (highlighted in green and orange, respectively) for probe 1 versus 3 (n = 248). d, Volcano plot displaying enriched proteins 
(highlighted in green and orange, respectively) for probe 2 versus 3 (n = 209). Proteins were considered enriched with a >2-fold signal over control and a 
FDR <0.05. e, Overlap between enriched proteins in c and d in comparison with the known G4-associated proteins as available in G4IPDB41. Orange dots 
in c and d represent the enriched known G4-associated proteins. f,g, Distribution of the top UniprotKB keywords for biological process (f) and molecular 
function (g) of all the enriched proteins (256). DMSO, dimethylsulfoxide.
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One protein, HMGB2, displayed single-stranded DNA and dsDNA, 
but no G4 binding (Extended Data Fig. 4a–c), which indicates 
that HMGB2 may bind to the dsDNA adjacent to G4s or to the 
single-stranded opposite strand. Intriguingly, all the other six G4 
binding proteins displayed selectivity for different G4 topologies. 
Although SMARCA4, TTF2 and DDX24 each showed a preference 
for a particular G4 sequence, RBM22, UHRF1 and DDX1 bound 
equally strongly to all parallel G4s (Myc, Kit1 and Kit2) and well 
to hybrid-type G4 (BCL2) (Fig. 4a). Importantly, our findings 
for DDX1 are in line with its reported G4 binding affinity, which 
validates the approach45. Notably, RBM22 showed a particularly 
high enrichment of relative intensity for G4s (Myc, Kit1, Kit2 and 
BCL2) compared with that of the 10% lysate control (Fig. 4a and 
Supplementary Table 5).
In principle, these affinity-enrichment experiments cannot dis-
tinguish direct G4 binders from proteins that are co-precipitated. 
Therefore, we carried out enzyme-linked immunosorbent assays 
(ELISAs) to assess the binding affinities for a selection of purified 
recombinant proteins (SMARCA4, UHRF1, DDX1, DDX24 and 
RBM22) (Supplementary Table 6). All five candidates displayed 
selective and high-affinity binding to G4s. SMARCA4 bound 
G4 Kit1 with Kd = 40.6 ± 5.1 nM (Fig. 4b). UHRF1 showed tight 
binding to G4 Kit1 with Kd = 1.2 ± 0.2 nM, which is more than 7-fold 
lower than that of its known substrate hemi-methylated dsDNA 
(Kd = 8.5 ± 1.1 nM) and 20-fold lower than its unmethylated duplex 
control (Kd = 21.2 ± 3.5 nM) (Fig. 4c). Similarly, DDX1 and DDX24 
showed a low nanomolar affinity to G4 Myc (Kd = 5.1 ± 1.1 nM) and 
Kit1 (Kd = 58.2 ± 14.1 nM), respectively (Fig. 4d,e). RBM22 selec-
tively bound to both DNA and RNA G4s and a preference for RNA 
NRAS G4 (Kd = 52.1 ± 11.3 nM) was observed (Fig. 4f and Extended 
Data Fig. 4d). Consistent with the affinity-enrichment experiments, 
considerably weaker or negligible binding was observed towards the 
control oligomers.
The affinity enrichment coupled with western blot analysis and 
ELISA experiments confirmed that our novel CMPP approach 
identifies genuine G4-interacting proteins in cells.
SMARCA4 binds at endogenous G4 in chromatin. Chromatin 
architecture is tightly linked to the presence of endogenous DNA 
G4s22 and may affect the binding of protein interactors. To further 
validate G4 binding interactions in a chromatin context, we focused 
on the candidate interactor SMARCA4, which is a part of the SWI/
SNF chromatin remodelling complex that plays a key role in tran-
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Fig. 4 | Validation of novel nuclear G4-selective binding proteins. a, Affinity enrichment coupled with western blot analysis of selected candidates 
for different topologies of G4 structures and control oligonucleotides (G-runs are highlighted in bold). A representative blot from two independent 
experiments with similar results is shown. b–e, Binding curves (the indicated Kd values were generated by ELISA) for the human recombinant full-length 
SMARCA4 protein to G4 Kit1, the single-stranded mutant (ss mutKit1) and double-stranded Kit1 (ds Kt1) (b), UHRF1 protein to G4 Kit1, ss mutKit1, Kit1 
hemi-methylated dsDNA and ds Kit1 (c), DDX1 protein to G4 Myc, ss mutMyc and ds Myc (d), DDX24 protein to G4 Kit1, ss mutKit1 and ds Kit1 (e) and 
RBM22 protein to G4 NRAS and its mutant (mutNRAS) (f). Mean and error (± s.d.) are from three independent experiments (n = 3). a.u., arbitrary units.
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been mapped to open chromatin regions and promoters of highly 
expressed genes22, SMARCA4 may be linked to G4 function.
We focused on human K562 chronic myelogenous leukae-
mia cells in which we previously mapped endogenous G4s via G4 
ChIP-seq21,30. In this cell line, we performed SMARCA4 ChIP-seq 
and identified 28,265 SMARCA4 high-confidence binding sites 
from three biological replicates (Extended Data Fig. 5a). Strikingly, 
we observed that the majority of endogenous G4s (7,565 of 8,995, 
84%) overlapped with SMARCA4 binding sites (Fig. 5a,b). Moreover, 
the SMARCA4 ChIP-seq signal was highly enriched and centred on 
endogenous G4 sites supportive of a direct SMARCA4-G4 binding 
interaction in chromatin (Fig. 5c). In contrast, no particular signal 
enrichment was observed at control sites that have the biophysi-
cal potential to form G4 single-stranded human DNA (potential 
G4s)20,47, but do not actually form folded G4 structures in chromatin 
for this cell line (Fig. 5c). Thus, the data show SMARCA4 binds to 
folded G4 secondary structures in chromatin, but not to the under-
lying G-rich dsDNA primary sequence in chromatin.
Investigating SMARCA4 binding sites at different functional 
genomic regions, we observed the largest proportion of SMARCA4-G4 
co-localization at promoters (42% of peaks), which suggests that these 
interactions may play a particular role in SMARCA4 promoter activ-
ity (Fig. 5d)48. In addition, although most SMARCA4 binding sites 
contained A/T-rich motifs (Extended Data Fig. 5b), a dominant 
G-rich motif was found in binding sites marked by endogenous G4s, 
which supports a direct binding to G4 structures and indicates an 
important alternative mode of recruitment to chromatin.
Discussion
Here we present a chemical CMPP approach to identify the cel-
lular interactome of DNA G4 structures in native chromatin. The 
method employs functionalized, structure-specific small-molecule 
ligands that bind to G4s and mediate proximity labelling of endog-
enous G4 binding proteins via photoactivatable diazirine groups. 
Compared with proteomic approaches carried out in vitro, the 
in situ capture in cells takes into account the local chromatin envi-
ronment in a functioning cell and should also facilitate the detection 
of transient G4-protein interactions that are lost during cell lysis or 
washing steps7.
Using the approach, we identified several hundred G4-associated 
proteins of which some were known G4-binders and many were 
not previously described. Several new G4 binding proteins were 
separately validated by in vitro assays and shown to be specific, 
high-affinity G4 binders. Given their distinct properties and vari-
ous functions in biological processes, these proteins may play dif-
ferent key roles in regulation of the endogenous G4 landscape and 
G4 biology. The protein SMARCA4, which is part of a chroma-
tin remodelling complex, was followed up further using genomic 
ChIP-seq methodology to demonstrate that SMARCA4 does, 
indeed, bind substantially to genomic sites in which G4 structures 
have been detected. This outcome confirms that our CMPP meth-
odology does identify proteins that bind to G4 structures in cellular 
chromatin, particularly at gene promoters, and also implicates that 
SMARCA4-G4 interactions may be important for transcriptional 
control. Further experiments that involve protein knockdown or 
overexpression coupled with G4 ChIP-seq may ultimately help elu-
cidate the associated mechanisms in more detail.
Although the CMPP probes were employed for relatively short 
treatment times, we cannot rule out the possibility that the ligands 
partially influence the endogenous G4 landscape and interactome. 
In this study and in other work35, PDS and G4-interacting proteins 
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Fig. 5 | SMArCA4 is enriched at endogenous G4s. a, Example genome browser view for XYLB, TMCC6 and LARP1. Signal tracks from ChIP-seq and control 
input as well as consensus peaks are shown for SMARCA4 (black) and G4s (blue). Sequences that have the biophysical potential to form G4s are shown 
for plus and minus strands (potential G4s, grey). b, Overlap of SMARCA4 and endogenous G4 high-confidence peaks. c, Occupancy profiles of SMARCA4 
endogenous G4 sites (left) and potential G4s (right). d, Proportion of SMARCA4 and G4 ChIP-seq peaks across different genomic features. TSS, 
transcription start site; UTR, untranslated region; TES, transcription end site; Rep, replicate.
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the situation can be more complex at high PDS concentrations, 
in which it has been shown to inhibit the binding of certain pro-
teins to G4s34,49. In addition, G4 ligands may induce the stabiliza-
tion of weaker, more transient G4s or alter the folded topology of 
G4s in ways that may influence protein binding. For these reasons 
it is essential to validate candidate G4 interactors with orthogonal 
approaches in vitro and in untreated cells, as we show in this study. 
We were mindful of observations that prolonged treatment with G4 
ligands can induce DNA damage and recruit associated proteins16. 
Therefore, we limited ligand treatment times and concentrations to 
avoid potential artefacts and did not observe a particular enrich-
ment of DNA damage-related proteins in our experiments.
In principle, the approach we describe here should be applica-
ble to a wide range of cell types and cell states, which in turn may 
help reveal specific differences in G4 interactomes and biology. 
During the revision of this article, we became aware of an inde-
pendent study that involved a pyrrolidine derivative of PDS50 and 
reported the identification of G4-related proteins in human SV589 
and MM231 cells51. Although we noted some overlap between the 
studies (61 shared protein candidates), which somewhat validates 
the independent approaches, most of the G4-associated proteins 
identified by our CMPP approach were not found in the indepen-
dent study. The different outcomes may have arisen due to varia-
tions in protein expression levels, chromatin states and G4 biology 
between the different cell lines. There were also some important 
technical differences between the two studies, which may have con-
tributed to differences in the outcomes. In our study, we fraction-
ated the nuclear proteins to focus on chromatin-associated proteins 
involved in G4 biology, and also to minimize the masking of physio-
logically relevant DNA G4 interactors by high-abundance, cytosolic 
RNA-binding proteins (for example, ribosomal proteins and elon-
gation factors)52. In addition, we employed the diazirine crosslinker 
control 3, which lacks a G4 binding moiety to account for and factor 
out background binding (Methods), as considerable off-target bind-
ing to diazirine photocrosslinkers has been reported previously37,53.
Overall, our chemical method shows that it can provide an 
unbiased strategy for the global mapping of interacting proteins 
of nucleic acid structural features in live cells. Although this study 
focused on DNA G4 interactors, we also identified several candi-
dates that are annotated as RNA-binding proteins. PDS can bind 
both DNA and RNA G4s with comparable affinity43 and, therefore, 
some of the identified proteins might, in principle, bind to nuclear 
RNA G4s. We envisage that future studies with RNA G4-specific 
probes49 might employ a similar approach to explore endogenous 
RNA G4-protein interactions. We also envision that the general 
principle will enable further studies to map endogenous interac-
tomes of other nucleic acid structural features.
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Methods
Detailed synthetic procedures and full characterization of photoPDS-1 (1) and 
photoPDS-2 (2), biophysical assays and more detailed methods as well as general 
information are described in the Supplementary Information.
Cell culture. Human embryonic kidney HEK293T cells (ATCC, CRL-3216) 
were grown in high-glucose DMEM (l-glutamine and pyruvate plus, GIBCO) 
supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS). Human 
chronic myelogenous leukaemia K562 cells (ATCC, CCL-243) were cultured in 
RPMI1640 (Glutamine plus, Life Technologies) supplemented with 10% FBS (Life 
Technologies). Both cell lines were grown at 37 °C in a 5% CO2 atmosphere. Cells 
used in the experiments were passaged at least twice after being thawed. Cells were 
tested periodically for mycoplasma contamination.
Co-binding-mediated proximity labelling of BG4. G4 Myc (7.3 µM) and the 
single-stranded mutated oligonucleotides were annealed in 10 mM Tris, pH 7.4, 
200 mM KCl and ds Myc in 10 mM Tris, pH 7.4, 200 mM NaCl. The G4-specific 
antibody BG417 (5 µl of 6.6 µM in PBS) was then incubated with 5 µl of annealed 
oligonucleotides at room temperature by gently shaking for 1 h, followed by adding 
5 µl of the indicated probes in 10 mM Tris HCl, pH 7.4, 100 mM KCl and incubated 
at room temperature for another hour. The solution was directly irradiated under 
365 nm light on ice for 10 min, and 1.7 µl of the ‘click’ mixture (2 μl of 50 mM 
CuSO4 in H2O, 2 μl of 50 mM TCEP (tris(2-carboxyethyl)phosphine) in H2O, 
1 μl of 10 mM TAMRA-azide in DMSO and 5 μl of 2 mM TBTA (tris((1-benzyl-
1H-1,2,3-triazol-4-yl)methyl)amine) in 1/4 DMSO/t-BuOH) was added and the 
mixture was gently shaken at room temperature for 1 h. Next, 5.6 µl of LDS loading 
buffer (4×) was added and the solution was heated at 70 °C for 10 min. Each sample 
(~22 μl) was loaded and separated by SDS-PAGE (NuPAGE 4 to 12% and Bis-Tris, 
1.0 mm), visualized on a Bio-Rad ChemiDoc MP system and the obtained images 
processed using Image Lab (version 6.1.0) software. Three biological replicates 
were performed.
Proximity labelling of G4 interactomes in live cells. The protocol was adapted 
from that described previously13. For gel-based experiments, HEK293T cells 
were grown in 6 cm dishes to a ~90% confluence at the time of treatment. Cells 
were carefully washed with 5 ml of Dulbecco’s phosphate-buffered saline (DPBS) 
(GIBCO) and then incubated with the indicated probe-containing fresh FBS-free 
DMEM media (2.5 ml) at 37 °C for 1 h, followed by direct irradiation under 365 nm 
light (UVP CL-1000 Ultraviolet Crosslinker, Fisher Scientific) on ice for 10 min. To 
harvest cells in cold DPBS (3 ml) they were scraped, centrifuged (300g, 5 min, 4 °C) 
and then washed with cold DPBS twice. Cell pellets were either treated directly or 
kept frozen at –80 °C until use. For MS-based experiments, a similar protocol as 
that above was used with minor modifications, which included that HEK293T cells 
were grown in 15 cm dishes to 80–90% confluence and then treated with 15 cm 
fresh FBS-free media that contained the indicated probes.
Nuclear protein extraction for gel- and MS-based analysis. The cell pellets for 
6 cm and 15 cm dishes were gently resuspended in 250 μl and 2.25 ml, respectively, 
of Hypotonic Buffer (10 mM HEPES, pH 7.4, 10 mM KCl and 1.5 mM MgCl2) 
with a protease inhibitor cocktail (PIC) (ThermoFisher, catalogue no. 78438) 
by pipetting several times and swelled on ice for 15 min. NP-40 (10%, 12.5 and 
112.5 μl, respectively) was added and the pellets were vortexed at the highest 
setting for 10 s, centrifuged (900g, 10 min, 4 °C) to afford the nuclear pellets, which 
were then washed once with Hypotonic Buffer (250 μl and 1.5 ml, respectively). 
The isolated nuclear pellets were lysed in 50 and 250 μl, respectively, of high-salt 
Hypotonic Buffer (10 mM HEPES, pH 7.4, 400 mM NaCl, 10 mM KCl and 1.5 mM 
MgCl2) that contained PIC, 0.5% NP-40 and 2 mM phenylmethylsulfonyl fluoride, 
followed by adding 0.25 and 1.25 μl, respectively, of benzonase (Sigma-Aldrich, 
catalogue no. E1014) and incubating on ice for 30 min with vortexing at 10 min 
intervals. The lysates were centrifuged (16,000g, 10 min, 4 °C) to give the 
supernatant that contained nuclear proteome, which was transferred to a clean 
protein LoBind tube, and the protein concentration was determined by a BCA 
(bicinchoninic acid) protein assay.
Gel-based analysis of probe-labelled nuclear G4 interactomes. Nuclear proteins 
(100 μg) were diluted with 50 mM HEPES, pH 7.4, to 80 μl in a clean 1.5 ml 
microcentrifuge tube. To dissolve the proteins, 10 μl of 4% SDS 50 mM HEPES,  
pH 7.4, was added, followed by adding 10 μl of a freshly prepared click mixture 
(2 μl of 50 mM CuSO4 in H2O, 2 μl of 50 mM TCEP in H2O, 1 μl of 10 mM 
TAMRA-azide in DMSO and 5 μl of 2 mM TBTA in 1/4 DMSO/t-BuOH). The 
mixture was gently shaken at room temperature for 1 h, followed by adding 
prechilled methanol (400 μl) and keeping it at –20 °C overnight. The precipitated 
protein pellets were collected by centrifuge (16,000g, 10 min, 4 °C) and washed 
with prechilled methanol (400 μl). After drying the pellets at room temperature for 
5 min, 50 μl of a 1× LDS sample buffer that contained 2.5% v/v 2-mercaptoethonal 
was added and the solution was heated at 95 °C for 10 min. The sample (20 μ) 
was loaded per gel lane for SDS-PAGE (NuPAGE 4 to 12% and Bis-Tris, 1.0 mm) 
analysis, visualized by in-gel fluorescence scanning on a Bio-Rad ChemiDoc MP 
system. Three biological replicates for each experiment were performed.
Enrichment of probe-labelled nuclear G4 interactomes for MS-based analysis. 
Nuclear proteins (700 μg) were diluted with 50 mM HEPES to 560 μl in a clean 5 ml 
microcentrifuge tube, to which 70 μl of 4% SDS 50 mM HEPES, pH 7.4, was added 
followed by 70 μl of a freshly prepared click mixture (14 μl of 50 mM CuSO4 in H2O, 
14 μl of 50 mM TCEP in H2O, 7 μl of 10 mM Biotin-PEG3-azide in DMSO and 35 μl 
of 2 mM TBTA in 1/4 DMSO/t-BuOH). The mixture was incubated by rotating 
at room temperature for 1 h, followed by adding prechilled methanol (2.8 ml) and 
then left at –20 °C overnight for protein precipitation. The solution was centrifuged 
(16,000g, 10 min, 4 °C) and the obtained protein pellets were washed with 
prechilled methanol (2.8 ml 2×). After drying at room temperature for 5 min, the 
nuclear proteins were redissolved in freshly prepared 0.2% SDS urea (625 μl, 6 M in 
DPBS) by sonication. The protein solution was then transferred to a 2 ml Protein 
Lobind microcentrifuge tube, followed by adding 62.5 μl of a 1:1 mixture of TCEP 
(200 mM in DPBS) and potassium carbonate (600 mM in DPBS), and the mixture 
was incubated at 37 °C for 30 min to reduce the disulfides. Alkylation of the free 
thiols was performed by adding 87.5 μl of iodoacetamide (400 mM in DPBS) and 
the mixture was incubated at room temperature for 30 min in the dark. Then, 25 μl 
of 10% SDS in DPBS was added, followed by adding DPBS (1,075 μl) to dilute the 
solution to 0.2% SDS, and the solution was incubated with 100 μl of streptavidin 
magnetic beads (Dynabeads, MyOne, Streptavidin C1, Invitrogen, catalogue 
no. 65002), prewashed with DPBS (1.5 ml 3×), at room temperature for 1 h with 
gentle rotation. The magnetic beads were then sequentially washed (changing 
tubes between each washing buffer and every single Tris and ammonium 
bicarbonate wash) with 2% SDS in H2O at room temperature (2 ml 2×, one for 
5 min and the other for 10 min), washing buffer 1 (0.1% sodium deoxycholate, 
1% Triton X-100, 500 mM NaCl, 1 mM EDTA and 50 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid, pH 7.5) at 4 °C (2 ml 2×, 5 min each), washing 
buffer 2 (250 mM LiCl, 0.5% NP-40, 0.5% sodium deoxycholate, 1 mM EDTA and 
10 mM Tris, pH 8.0) at 4 °C (2 ml 2×, 5 min each), 50 mM Tris (2 ml 2×) and freshly 
prepared cold 100 mM NH4HCO3 in H2O (400 μl 2×). Beads were either treated 
directly or kept frozen at –20 °C until use.
Label-free quantitative proteomics data analysis. The label-free experiment 
consisted of 24 samples distributed in 6 groups, which included the treatments 
with the G4-ligand probes 1 and 2 and the negative control probe 3. Missing 
values for 3 are imputed by replacing them with the minimum value, whereas 
those for 1 and 2 are imputed using the nearest neighbour method after removing 
peptides missing in more than half of samples in each group. The peptide 
intensities of the filtered peptides were analysed using the Bioconductor library 
qPLEXanalyzer54. To find differentially expressed proteins, a statistical analysis 
was carried out using the Bioconductor library limma55. Visualization of the 
results was performed with volcano plots and Venn diagrams using the R libraries 
ggplot2 (https://cran.r-project.org/web/packages/ggplot2/index.html), ggrepel 
(https://cran.r-project.org/web/packages/ggrepel/index.html) and VennDiagram 
(https://cran.r-project.org/web/packages/VennDiagram/index.html). UniprotKB 
keywords of differentially expressed proteins were extracted using the Retrieve/
ID mapping online functionality56. The list of 79 G4-associated proteins in 
humans was downloaded from G4IPDB41 (accessed 20th November, 2020). The 
code is available on the github page dedicated to this study, https://github.com/
sblab-bioinformatics/cmpp
G4 affinity enrichment and western analysis. HEK293T cells were grown to 
~80% confluence at the time of treatment. Cell pellets were swelled at a density 
of 10 million cells per 300 µl in a low salt buffer (20 mM HEPES, pH 7.4, 10 mM 
NaCl, 3 mM MgCl2, 0.2 mM EDTA and 1 mM dichlorodiphenyltrichloroethane 
(DTT)) that contained PIC on ice for 15 min. Then, 15 μl of 10% NP-40 was added 
and pellets were vortexed for 1 min, centrifuged (900 g, 10 min, 4 °C) to afford the 
nuclear pellets, which were then washed with low salt buffer. The nuclear pellets 
were lysed at a density of 30 million cells per 250 µl in high salt buffer (20 mM 
HEPES, pH 7.4, 500 mM NaCl, 3 mM MgCl2, 0.2 mM EDTA, 0.5% NP-40 and 
1 mM DTT) that contained PIC by sonicating in a Diagenode Bioruptor Plus (ten 
cycles, 30 s on and 30 s off at each high setting, 4 °C). The lysates were centrifuged 
(16,000g, 10 min, 4 °C) to afford the nuclear proteins, and the concentration was 
measured using the BCA protein assay.
A slurry (50 µl) of Streptavidin MagneSphere paramagnetic beads (Promega, 
catalogue no. Z5481) was prewashed with pull-down buffer (25 mM HEPES, 
10.5 mM NaCl, 110 mM KCl, 1 mM MgCl2, 0.01 mM ZnCl2, 20% v/v glycerol, 0.1% 
Igepal C-630, 1 mM DTT and PIC) that contained 3% bovine serum albumin 
(BSA) and 0.2 g l–1 salmon sperm DNA (Invitrogen, catalogue no. 15632011) three 
times (2 ml), and then 75 µg of nuclear proteins was added into 500 μl of pull-down 
buffer that contained 3% BSA and 0.2 g l–1 salmon sperm DNA, and precleared by 
incubating with the prewashed beads at 4 °C for 2 h. Meanwhile, another 50 µl of 
beads was washed in the same manner as above. Then, 50 µl of 10 µM annealed 
biotinylated oligonucleotides (Sigma-Aldrich) was added into 500 µl of pull-down 
buffer and incubated with the prewashed beads by rotation at room temperature 
for 30 min. The oligonucleotide immobilized beads were then washed with 
pull-down buffer (2 m 3×) and incubated with the precleared lysates (500 µl) by 
rotation at 4 °C overnight. The beads were washed with cold pull-down buffer 
(500 µl 5×) and the biotinylated oligonucleotides on the beads were eluted in 25 µl 
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of LDS sample buffer that contained freshly prepared 50 mM DTT by heating at 
70 °C for 10 min. Next, 3 µl of the LDS sample buffer were analysed with capillary 
electrophoresis in a Wes Simple Western system (ProteinSimple) according to 
the instructions of the manufacturer, or samples were kept frozen at –20 °C until 
analysis. The primary antibodies (Supplementary Table 4) and the corresponding 
secondary antibodies (anti-rabbit) were used to detect the target signal bands, 
which were analysed by the software Compass for SW (ProteinSimple).
Enzyme-linked immunosorbent assay. ELISAs for binding affinity and specificity 
were performed as described previously17 with minor modifications. Briefly, 
biotinylated oligonucleotides were bound to Pierce streptavidin-coated high 
capacity plates (ThermoFisher) followed by blocking with 3% BSA and incubation 
with full-length recombinant human GST-tagged UHRF1 (Abnova, catalogue no. 
H00029128-P01) and DDX24 (Abnova, catalogue no. H00057062-P01), HIS-tagged 
SMARCA4 (Abcam, catalogue no. ab82237), RBM22 (OriGene, TP760056) and 
Myc/DDK-tagged DDX1 (OriGene, TP308769) in ELISA buffer (100 mM KCl and 
50 mM KH2PO4, pH 7.4). After three washes with the ELISA buffer, detection was 
achieved with an anti-GST HRP (horseradish peroxidase)-conjugated antibody 
(Abcam, catalogue no. ab3416) diluted to 1:5,000, anti-FLAG HRP-conjugated 
antibody (Abcam, ab1238,) diluted to 1:15,000 or anti-HIS HRP-conjugated 
antibody (BioLegend, catalogue no. 652503) diluted to 1:3,000 in an ELISA buffer 
that contained 3% BSA and 3,3′,5,5′-tetramethylbenzidine ELISA substrate (slow 
kinetic rate) (Abcam, ab171525). Signal intensity was measured at 450 nm on a 
SPECTROstar nano microplate reader (BMG Labtech). Kd values were calculated 
from binding curves assuming a one-site binding model in GraphPad Prism, and 
standard error of means from three replicates are reported.
SMARCA4 ChIP-seq. SMARCA4 ChIP-seq was performed essentially as 
described previously57. Briefly, cells were first crosslinked in 2 mM disuccinimidyl 
glutarate (ThermoFisher) in PBS for 30 min and then in 1% formaldehyde in the 
medium for 10 min at room temperature. The cells were quenched with 0.125 M 
glycine for 5 min and washed twice in ice-cold PBS. Chromatin was isolated and 
prepared using a ChIP-qPCR Kit (Chromatrap) and sonicated using a Bioruptor 
Plus (Diagenode) to an average DNA size of 150–400 base pairs. Magnetic protein 
G Dynabeads (ThermoFisher) were washed with PBS that contained 1% w/v BSA 
(Sigma-Aldrich), incubated with 5 µg of ChIP-grade antibody against SMARCA4 
(Abcam, ab110641) for 1 h at room temperature and washed five times with 
PBS that contained 1% w/v BSA. Solubilized chromatin from 5 × 106 cells was 
immunoprecipitated with antibody conjugated beads in RIPA buffer (50 mM Tris 
pH 7.4, 150 mM NaCl, 1% Igepal CA-630 and 0.5% sodium deoxycholate) for 
12 h at 4 °C. Magnetic beads were washed 5× with RIPA buffer and chromatin 
was eluted. After crosslinking reversal, RNAase A (Ambion) and proteinase 
K (ThermoFisher) treatment, ChIP DNA was extracted using a Min-Elute 
purification kit (Qiagen). Sequencing libraries of ChIP DNA and input controls 
were generated using the NEBNext Ultra DNA Library Prep Kit for Illumina (NE 
Biolabs) following the manufacturer’s protocol.
SMARCA4 ChIP-seq data analysis. Bioinformatics data analyses and processing 
were performed using Bash, R and Python programming languages. The following 
tools were also used: cutadapt (version 1.16)58, BWA (v0.7.15)59, Picard (v2.14.0; 
http://broadinstitute.github.io/picard), MACS2 (v2.1.1)60, bedtools61 (v2.26.0), 
SAMtools (v1.6)62, deepTools (v3.1.2)63 and Intervene (v0.6.4)64. Code is available 
in the github page dedicated to this study, https://github.com/sblab-bioinformatics/
cmpp. Raw fastq files were trimmed with cutadapt58 to remove adapter sequences 
and low-quality reads (mapping quality <10). Reads were aligned to the human 
reference genome (version hg19) with BWA59 and duplicates marked using Picard 
(v 2.14.0; http://broadinstitute.github.io/picard) and removed using SAMtools62. 
G4 ChIP and SMARCA4 ChIP peaks were called by MACS260 (q-value < 0.05). 
Peak overlaps in different replicates were visualized with Intervene64. Peaks were 
merged from replicates with bedtools61 and high confidence peaks were defined as 
those overlapping in two out of three replicates (SMARCA4) or five out of eight 
replicates (G4 ChIP-seq) as described previously21. Fragment coverage bigWig files 
were computed at a 50 base pair resolution, 200 base pair average fragment size and 
normalization to sequencing depth (RPKM) using deepTools63. Signal distribution 
from the SMARCA4 ChIP in K562 G4 ChIP-seq peaks and potential G4s was 
computed using the plotProfile function in deepTools63.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
The label-free quantitative proteomics data reported in this study are included 
in Supplementary_Dataset_CMPP, which contains peptide intensities, metadata 
and enriched proteins from the 1 versus 3 and 2 versus 3 statistical comparisons. 
The SMARCA4 ChIP-seq data have been deposited in the NCBI GEO repository 
under accession number GSE165124. The BG4 ChIP-seq data were generated in a 
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Extended Data Fig. 1 | Probes for co-binding-mediated proximity labelling of BG4 in vitro. a, Assessment of G4-ligand probes (1-3) of inducing thermal 
stabilization (ΔTm) on G4 Telo and G4 Myc using FRET melting assay. ΔTm of 1 and 2 at 1 μM on G4 Telo are 25 °C and 27 °C, respectively. ΔTm of 1 and 2  
at 1 μM on G4 Myc, are 14 °C and 13 °C, respectively. While ΔTm of 3 at 1 μM is 0. Mean is represented from two independent experiments (n = 2).  
b, Assessment of G4-binding affinity of PDS and 3 using fluorescence titration binding assay by measuring apparent Kd values. Mean and error (± S.D.) 
are represented from four independent experiments (n = 4). c, Structure verification of G4 Myc, single-stranded mutMyc and double-stranded Myc with 
circular dichroism (G-runs are highlighted in bold). Mean of three independent experiments (n = 3) is represented. d, Dose-dependent of CMPP of BG4 by 
1 and 2. Signals from TAMRA and Coomassie staining represent probe-specific labelling and loading input, respectively. Representative images from three 
independent experiments with similar results are shown.
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Extended Data Fig. 2 | Gel-based mapping of DNA G4-interacting proteins in human cells. a, Probe 1 and b, probe 2 display dose-depend protein 
labelling of nuclear proteomes in HEK293T cells. Representative gel images from three independent experiments with similar results are shown.  
c, CellTiter-Glo luminescent cell viability assay on probe treatment for 75 min to HEK293T cells under all conditions used in this study. Mean and  
error (± S.D.) are represented from four independent experiments (n = 4).
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Extended Data Fig. 3 | Structure verification of oligonucleotides. CD spectra obtained here match previously reported spectra of the well-characterized 
DNA G4 sequences (G-runs are highlighted in bold, see Supplementary Table 3) with different topologies showing distinct bands65,66, including parallel 
a,G4 Myc b, G4 Kit1 and c, G4 Kit2 by positive at ~260 nm and negative at ~240 nm; anti-parallel G4 TBA by positive at ~290 nm and ~240 nm, and 
negative at ~260 nm; d, hybrid G4 BCL2 by positive at ~290 nm and ~260 nm, and negative at ~240 nm. All G4 structures also share a positive band at 
~210 nm. While the corresponding single-stranded mutant and duplex controls have lost these features. Mean of three independent experiments (n = 3) is 
represented.
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Extended Data Fig. 4 | Protein validation by affinity enrichment coupled with western blot analysis and eLiSA. a, Affinity enrichment coupled with 
western blot analysis of HMGB2 for different topologies of G4 structures and control oligonucleotides. A representative blot from two independent 
experiments with similar results is shown. Structure verification of G4 Myc (b) and G4 Kit1 (c) and the indicated control oligonucleotides with CD 
spectroscopy. Curves are plotted by mean values of three independent experiments (n = 3). d, Binding curves with indicated dissociation constants (Kd) 
generated by ELISA for human recombinant full-length RBM22 protein to DNA G4 Myc, single-stranded mutant and Myc duplex DNA. Mean and  
error (± S.D.) are represented from three independent experiments (n = 3). G-runs are highlighted in bold.
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Extended Data Fig. 5 | Properties of SMArCA4 binding sites. a, Overlap of binding sites identified by SMARCA4 ChIP-seq in K562 chromatin across 
three biological replicates. Binding sites identified in at least two replicates were considered as high confidence binding sites. b, Binding motifs identified 
in SMARCA4 binding sites that are marked by or lack and endogenous G4. The top3 motifs identified by EM for Motif Elicitation (MEME)67 analysis are 
shown.
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